Dialyzer Classification and Mortality in Hemodialysis Patients: A 3-Year Nationwide Cohort Study
Overview
Affiliations
Dialyzers are classified as low-flux, high-flux, and protein-leaking membrane dialyzers internationally and as types I, II, III, IV, and V based on β-microglobulin clearance rate in Japan. Type I dialyzers correspond to low-flux membrane dialyzers, types II and III to high-flux membrane dialyzers, and types IV and V to protein-leaking membrane dialyzers. Here we aimed to clarify the association of dialyzer type with mortality. This nationwide retrospective cohort study analyzed data from the Japanese Society for Dialysis Therapy Renal Data Registry from 2010 to 2013. We enrolled 238,321 patients on hemodialysis who were divided into low-flux, high-flux, and protein-leaking groups in the international classification and into type I to V groups in the Japanese classification. We assessed the associations of each group with 3-year all-cause mortality using Cox proportional hazards models and performed propensity score matching analysis. By the end of 2013, 55,308 prevalent dialysis patients (23.2%) had died. In the international classification subgroup analysis, the hazard ratio (95% confidence interval) was significantly higher in the low-flux group [1.12 (1.03-1.22), = 0.009] and significantly lower in the protein-leaking group [0.95 (0.92-0.98), = 0.006] compared with the high-flux group after adjustment for all confounders. In the Japanese classification subgroup analysis, the hazard ratios were significantly higher for types I [1.10 (1.02-1.19), = 0.015] and II [1.10 (1.02-1.39), = 0.014] but significantly lower for type V [0.91 (0.88-0.94), < 0.0001] compared with type IV after adjustment for all confounders. These significant findings persisted after propensity score matching under both classifications. Hemodialysis using protein-leaking dialyzers might reduce mortality rates. Furthermore, type V dialyzers are superior to type IV dialyzers in hemodialysis patients.
A Study on the Safety and Efficacy of an Innovative Hydrophilic Dialysis Membrane.
Maduell F, Escudero-Saiz V, Cuadrado-Payan E, Rodriguez-Garcia M, Gomez M, Rodas L Membranes (Basel). 2025; 15(1).
PMID: 39852270 PMC: 11767910. DOI: 10.3390/membranes15010030.
Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.
Abe M, Kikuchi K, Wada A, Nakai S, Kanda E, Hanafusa N Sci Rep. 2024; 14(1):10272.
PMID: 38704419 PMC: 11069571. DOI: 10.1038/s41598-024-60831-y.
Expanded hemodialysis: what's up, Doc?.
Garcia-Prieto A, De la Flor J, Coll E, Iglesias E, Reque J, Valga F Clin Kidney J. 2023; 16(7):1071-1080.
PMID: 37398691 PMC: 10310509. DOI: 10.1093/ckj/sfad033.
How should we treat acute kidney injury caused by renal congestion?.
Abe M, Hemmi S, Kobayashi H Kidney Res Clin Pract. 2023; 42(4):415-430.
PMID: 37098670 PMC: 10407633. DOI: 10.23876/j.krcp.22.224.
Abe M, Masakane I, Wada A, Nakai S, Nitta K, Nakamoto H Sci Rep. 2021; 11(1):20616.
PMID: 34663871 PMC: 8523692. DOI: 10.1038/s41598-021-99834-4.